Wedbush Has Pessimistic View of Nuvation Bio Q3 Earnings
Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Analysts at Wedbush dropped their Q3 2025 EPS estimates for Nuvation Bio in a research report issued on Monday, March 3rd. Wedbush analyst D. Nierengarten now expects that the company will post earnings of ($0.17) per share for the quarter, down from.
Publicado el: 2025-03-07 12:49:51
Autor: lulegacy, Fuente: lulegacy
Compartir: 
